Chat bcg

Author: c | 2025-04-24

Share This: Share BCG Coffee Chat for PhDs and Postdocs on Facebook Share BCG Coffee Chat for PhDs and Postdocs on LinkedIn Share BCG Coffee Chat for PhDs and Postdocs on X; Copy Link; Date: Monday, Ma Time: 6pm - 7pm Location:

Covid and BCG treatment - Cancer Chat

Toggle fswatchToggle relay of fellowship chat received to /bc/bccmd toggle silentcmdToggle display of 'CMD: [command]' echo/bccmd toggle savebycharToggle saving of custom UI window settings to Window or CharName sections of the configuration file/bc/bc your text hereSend "your text here" to the server./bct/bct ToonName your text hereSend "your text here" to ToonName./bct ToonName //commandSend /command to ToonName./bca/bca //commandSend /command to all connected clients, excluding the client you issued the command from./bcaa/bcaa //commandSend /command to all connected clients, including the client you issued the command from./bcg/bcg //commandSend /command to all connected clients in your group, excluding the client you issued the command from./bcg your text hereSend "your text here" to all connected clients in your group, excluding the client you issued the command from./bcga/bcga //commandSend /command to all connected clients in your group, including the client you issued the command from./bcga your text hereSend "your text here" to all connected clients in your group, including the client you issued the command from./bcz/bcz //commandSend /command to all connected clients in the same zone as the client you issue the command from, excluding the client you issued the command from. *Requires MQ2NetBots to be loaded and active*/bcz your text hereSend "your text here" to all connected clients in the same zone as the client you issue the command from, excluding the client you issued the command from. *Requires MQ2NetBots to be loaded and active*/bcza/bcza //commandSend /command to all connected clients in the same zone as the client you issue the command from, including the

Advice about Bcg - Cancer Chat

Terms of market growth but are also losing market share. Can I customize the BCG Matrix template in Creately? Yes, Creately allows full customization. You can adjust text, colors, and the size of the elements to better represent your analysis. Additionally, you can add notes, comments, or other visual elements to personalize your matrix. How often should I update my BCG Matrix template? You should update your BCG Matrix template whenever there is a significant change in market conditions, product performance, or strategic direction. Typically, it’s done annually or during strategy reviews. How do I interpret the size of bubbles in Creately's BCG Matrix? In Creately’s BCG Matrix template, the size of the bubbles can represent a product’s revenue or contribution to the business. Larger bubbles indicate more profitable or impactful products. How do I access the BCG Matrix template in Creately? You can access the BCG Matrix template by logging into Creately, searching for "BCG Matrix" in the template library, and selecting the one that suits your needs. The template is customizable and easy to use. Can I change the color of quadrants or bubbles in Creately’s BCG Matrix template? Yes, you can fully customize the BCG Matrix in Creately. You can change the colors of the quadrants, bubbles, and text to fit your branding or presentation style. This helps make the matrix more visually appealing and aligned with your analysis.

BCG Coffee Chat : r/MBA - Reddit

Into the bladder. Induction intravesical BCG is prescribed three to four weeks after TURBT. Up to two courses of induction intravesical chemotherapy may be prescribed.Indications:High-grade non-invasive bladder tumor (high grade Ta)Urothelial carcinoma in situ (Tis)Low-grade or high-grade bladder tumor with invasion into the lamina propria (T1)4. Maintenance intravesical BCG immunotherapyMaintenance intravesical BCG immunotherapy includes six to twelve monthly instillations of BCG into the bladder.Indication:Maintenance intravesical BCG immunotherapy is a treatment option after complete endoscopic resection of recurrent or residual bladder tumor(s) in patients who have recurrent or residual bladder tumor(s) after one or two courses of induction intravesical mitomicyn C chemotherapy or intravesical BCG immunotherapy.Specific Intravesical Therapies:5. Intravesical mitomycin CThe most commonly administered adjuvant intravesical chemotherapeutic agent is mitomycin C. Immediate adjuvant intravesical mitomycin C administered within 24 hours of TURBT benefits a significant proportion of patients with non-muscle invasive bladder cancer. Mitomycin C decreases the rate of non-muscle invasive bladder cancer recurrence. It does not affect or prevent the progression of non-muscle invasive bladder cancer to higher disease stages.Immediate intravesical mitomycin C chemotherapy within 24 hours after complete endoscopic resection of a bladder tumor(s) is one of the management options for low grade non-invasive bladder cancer (Ta). Adjuvant intravesical mitomicyn C is not considered a first-line treatment after complete endoscopic resection of high-risk non-muscle invasive bladder cancer including high grade bladder tumors, urothelial carcinoma in situ (Tis) and bladder tumors with invasion into the lamina propria (T1).Side effects and complications of intravesical mitomycin CMyelosuppression due to systemic absortion. Prolonged myelosuppression can be seen in the setting of bladder perforation and peritoenal absorbtion of chemotherapy.Skin rash.Non-infectious cystitis with irritative lower urinary tract symptoms (LUTs): dysuria, frequency, urgency.Superimposed bacterial cystitis, urinary tract infection.Death.BCG intravesical immunotherapyIntravesical instillation of the biologic response modifier BCG after complete endoscopic resection of bladder tumor(s) is a. Share This: Share BCG Coffee Chat for PhDs and Postdocs on Facebook Share BCG Coffee Chat for PhDs and Postdocs on LinkedIn Share BCG Coffee Chat for PhDs and Postdocs on X; Copy Link; Date: Monday, Ma Time: 6pm - 7pm Location: BCG Consultant on Digital Transformation. Sign up to chat. Sign up or Log in to chat

Bleeding after bcg therapy. - Cancer Chat

Edit or Customize the free BCG Matrix template to easily analyze your business portfolio. Visualize market growth, market share, and optimize strategic decision-making with this customizable BCG Matrix template. You can easily edit this template using Creately's block diagram maker. You can export it in multiple formats like JPEG, PNG and SVG and easily add it to Word documents, Powerpoint (PPT) presentations, Excel or any other documents. You can export it as a PDF for high-quality printouts.What is a BCG Matrix TemplateA BCG Matrix template is a pre-designed framework or layout used to create a visual representation of a company's product portfolio, based on the Boston Consulting Group Matrix. It helps businesses easily categorize and plot their products or business units in the four quadrants of the matrix: Stars, Cash Cows, Question Marks, and Dogs. Instead of creating a BCG matrix from scratch, you can use a ready-made BCG Matrix template to quickly fill in details. BCG Matrix template has Y axis and X axis. X-axis represents Relative Market Share (from low to high). Y-axis represents Market Growth Rate (from low to high). The BCG Matrix template allows you to enter specific products, services, or business units into the quadrants. You can modify the template based on the company’s specific metrics.How to Use a BCG Matrix Template in CreatelyClick Edit the template of this template or Navigate to the Templates section in Creately, search for "BCG Matrix," and click Use Template or Add to Workspace to begin working. Drag a

BCG Coffee Chat for PhDs and Postdocs – UCLA

Well-established form of intravesical immunotherapy for non-muscle invasive bladder cancer. Low-grade non-invasive bladder tumors (Ta) are relatively resistant to BCG intravesical immunotherapy. In contrast, high grade bladder tumors, urothelial carcinoma in situ (Tis) and bladder tumors invading the lamina propria (T1) are more sensitive to BCG intravesical immunotherapy.One induction course of intravesical BCG immunotherapy involves six weekly instillations of BGC into the bladder urothelium starting two to three weeks after TURBT. Office cystoscopy and/or mapping bladder biopsies are performed 3 months after BCG administration to document treatment success. A second 6-week course of induction intravesical BCG may be used if residual bladder tumor is found and resected completely. Up to two courses of induction intravesical BCG are associated with a 20% to 60% decrease in the rate of bladder tumor recurrence.Prospective randomized clinical trials and meta-analyses have demonstrated a significant decrease in the rate of bladder tumor recurrence with intravesical BCG compared to intravesical mitomicyn C in patients with high risk non-muscle invasive bladder cancer including:High grade bladder tumors.Urothelial carcinoma in situ (Tis).Bladder tumors invading the lamina propria (T1).Response of non-muscle invasive bladder tumors to intravesical BCG varies by different clinical factors including:Patient age.General immune status.Previous exposure to BCG.Tumor characteristics such as location, stage, grade, antigenicity, and doubling time.Studies evaluating novel predictive factors of bladder tumor response to intravesical BCG immunotherapy are under way. These include microarray gene expression profiling of bladder tumors, evaluation of cytokine gene expression variants among others. At the present time it is not clear if intravesical BCG reduces the rate of disease progression of non-muscle invasive bladder tumors to higher disease stages.Randomized controlled studies indicate that maintenance BCG is associated with a further reduction of the risk of non-muscle invasive bladder cancer recurrence. Although the optimal maintenance schedule has not been defined by controlled comparison,

Recap: Sunny Lu and BCG’s Fireside Chat at

They arise in the setting of a cancerization field effect of the bladder urothelium. Complete endoscopic resection of all Tis tumors may not be possible.Intravesical BGG immunotherapy is mandatory after partial or complete resection of Tis tumors. In meta-analyses, intravesical BCG is associated with 70% to 75% initial complete response in patients with Tis. Forty to 50% of patients demonstrate a durable complete response over several years (> 5 years). Some studies suggest that intravesical BCG immunotherapy is associated with a 26% reduction in disease progression to higher stages of bladder cancer in patients with Tis.Adjuvant intravesical therapyThe most common and important indication for intravesical therapy is as adjuvant treatment after complete endoscopic resection of all visible non-muscle invasive bladder tumor(s). Intravesical therapy has not been definitely proven to delay progression of non-muscle invasive bladder tumors, to higher disease stage or grade. Adjuvant intravesical therapy delays and decreases the rate of recurrence of non-muscle invasive bladder cancer.Commonly prescribed forms of adjuvant intravesical therapies and their respective indications include:1. Immediate intravesical chemotherapyImmediate adjuvant intravesical chemotherapy involves the instillation of a single dose of chemotherapy into the bladder within 24 hours of TURBT.Indication:Low-grade non-invasive bladder tumor (Ta)A course of induction intravesical BCG immunotherapy is a preferred option for high-grade non-invasive bladder tumors (high grade Ta), low- and high-grade bladder tumors with invasion of the lamina propria (T1). The presence of any urothelial carcinoma in situ (Tis) mandates treatment with induction intravesical BCG immunotherapy.2. Induction intravesical chemotherapyOne course of induction intravesical chemotherapy includes six weekly instillations of chemotherapy into the bladder. Induction intravesical chemotherapy is prescribed three to four weeks after TURBT. Up to two courses of induction intravesical chemotherapy may be prescribed.Indication:Low-grade non-invasive bladder tumors (Ta)3. Induction intravesical BCG immunotherapyOne course of induction intravesical BCG immunotherapy includes six weekly instillations of BCG

BCG Side Effects and Complications - Cancer Chat

Detailed Amazon BCG Matrix Analysis 1. Introduction The Boston Consulting Group (BCG) growth-share matrix is a graphical planning tool for a company's products, services and stand alone business units to assess their standing and growth chances in the market. The basic purpose of a BCG matrix is to determine which units require investment for further expansion and growth and which units are self sufficient or not worthy of investments. The BCG matrix has market growth rate at the y-axis and market share at the x-axis. Let us analyze the BCG matrix of Amazon to understand the scenario better. 2. Background of Amazon Amazon was founded in 1994 by Jeff Bezos based in Seattle. Amazon was first launched as an online bookstore but the business model was so appreciated that gradually it moved on to become the world’s largest e-commerce store with a huge variety of products. It deals in books, music, films, household products, furniture, digital products, gadgets, garments and what not. Amazon has another business unit that deals with Amazon's digital service like Cloud and AWS etc. 3. Amazon BCG Matrix The BCG matrix of Amazon com helps us understand the current position of different products and services in the Amazon business model and we can also see the business level strategies for its business units. A BCG matrix is categorized into four types of products based on the market share and growth potential. These four types are dogs, stars, cash cows and question marks. Source: EdrawMax Online 3.1.. Share This: Share BCG Coffee Chat for PhDs and Postdocs on Facebook Share BCG Coffee Chat for PhDs and Postdocs on LinkedIn Share BCG Coffee Chat for PhDs and Postdocs on X; Copy Link; Date: Monday, Ma Time: 6pm - 7pm Location: BCG Consultant on Digital Transformation. Sign up to chat. Sign up or Log in to chat

aftereffects of BCG bladder treatment - Cancer Chat

Limited growth in this segment. Source: unsplash.com 4. Limitations of BCG Matrix Though the BCG matrix is a popular business planning and analysis tool, it has some limitations that affect its potential benefits. The first and the foremost limitation is the scop of this matrix. As we can see in the BCG matrix of Amazon, we are using this tool for analyzing different products of one company based on market share and growth rate. However, it was actually devised to study the business units owned by one group. So, the dynamics of production units or factories are very different from the products. Secondly, BCG is a very simple matrix which is an attractive feature but then , this over simplicity is a cause of reservation because many other factors also determine the market dynamic and growth in the market, e.g., geographical demographics, brand power, competition, etc. So, a decision based solely on the BCG matrix has a weak foundation. Also, this matrix does not take the gray areas into account. So, the market share can be either high or low but not medium and you can also not consider many relative measures. So, we can conclude that BCG is an important matrix but cannot be used individually to make critical decisions. EdrawMax Online Create 210+ types of diagrams online Access diagrams anywhere, anytime Everything in desktop + Templates Community Team management and collaboration Personal Cloud and Dropbox Integration EdrawMax Desktop Create 210+ types of diagrams Support Windows, Mac, Linux Full

Baltic Classifieds Group Share Chat. Chat About BCG Shares

Maintenance BCG administration at 3, 6, 12, 18, 24, 30, and 36 months is recommended, but dose reduction and delay or suspension of treatments is frequently needed to reduce side-effects.Immediate intravesical BCG immunotherapy within 24 hours of TURBT is not used in the management of non-muscle invasive bladder cancer.Side effects and complications of intravesical BCGThe following side effects and complications can be seen after intravesical instillation of BCG:Flu-like symptoms: fever, malaise, fatigue, myalgias, arthralgias.Systemic mycobacterial dissemination. This rare complication is seen most frequently in immunocompromised hosts (e.g., patient with lymphoproliferative disorder), debilitated and elderly patients.Granulomatous prostatis.Vesicocutaneous or enterovesical fistula tract formation.Non-infectious cystitis with irritative lower urinary tract symptoms (LUTs): dysuria, frequency, urgency.Superimposed bacterial cystitis, urinary tract infection.Death.Management of BCG refractory non-muscle invasive bladder cancerBladder tumor relapse after intravesical BCG is a common and challenging clinical scenario in the management of patients with non-muscle invasive bladder cancer. Several definitions of BCG-refractory non-muscle invasive bladder cancer exist.A clinically useful definition of BGC-refractory non-muscle invasive bladder cancer includes patients with the following characteristics:Persistent bladder tumor (s) after two induction courses of BCG intravesical immunotherapy.Urothelial carcinoma in situ (Tis) recurrence less Recurrence of Tis while receiving maintenance BGC intravesical immunotherapy.Relapse with invasive bladder tumor.The management options of BCG-refractory non-muscle invasive bladder cancer include:Radical cystectomy.In patients who are not candidates for cystectomy, intravesical chemotherapy with a different agent (gemcitabine, valrubicin, docetaxel and others) can be tried.Participation in a clinical trial.Contraindications for intravesical therapiesPatients in whom intravesical therapies should be avoided include:Suspected bladder perforation at the time of TURBT. In patients with bladder perforation at the time of endoscopic resection of bladder tumor, intraperitoneal administration and absorption of mitomycin C can cause significant toxicity and prolonged myelosuppression.Extensive TURBT.Severe allergic reactions to the specific intravesical therapeutic agent.Untreated urinary tract infection.Complications directly related to bladder catheterization:Traumatic injury to. Share This: Share BCG Coffee Chat for PhDs and Postdocs on Facebook Share BCG Coffee Chat for PhDs and Postdocs on LinkedIn Share BCG Coffee Chat for PhDs and Postdocs on X; Copy Link; Date: Monday, Ma Time: 6pm - 7pm Location:

Baltic Classifieds Group Plc (BCG) Share Chat

Entry Level | Mid Tier | High Tier | Enhanced Options | Building out a Custom Bolt Carrier Group The Bolt Carrier Group (BCG) is easily considered the heart of the AR platform. Rightfully so, considering the BCG is responsible for a large portion of the rifle's function. This article will go over some of our recommendations and things to look for when purchasing a bolt carrier group.Entry LevelAero Precision PRO BCGThe Aero PRO BCG is a fairly new addition to Aeros lineup. This is a step above their standard option, but it is well worth the extra cost as the BCG is one of the most critical components of your rifle. The PRO BCG features an 8620 carrier, a 9310 bolt, and a 4140 Extractor, Cam Pin, and Gas Key. C158 is our preferred bolt material, but 9310 can be stronger if properly heat treated. Mid TierBCM Bolt Carrier GroupBCM has long been one of our recommendations. They're simple, and they get the job done. The BCM bolt carrier group features a C158 bolt, tool steel extractor/ejector, and a properly staked chrome-lined gas key all housed in a phosphate carrier with a chrome-lined bore.Sons Of Liberty Gunworks BCGMuch like the BCM, this is another no-frills option that has a few enhancements over your standard "Mil-Spec" bolt carrier group. This BCG features a C158 bolt, 4340 extractors, and an S7 tool steel ejector. The gas key is made out of 4130 steel, is chrome lined as it should be, and includes enhanced Sprinco extractor springs, a sealed gas key, and properly staked gas key screws. The carrier is made out of 8620 steel and has a phosphate finish with a chrome-lined bore.High TierYou'll notice up until now we haven't recommended any special coatings. That's because a lot of the stuff currently being offered is marketing snake oil. A good Parkerized/Phosphate BCG will perform better than a cheap BCG that's marked up for a coating that doesn't offer much over standard offerings and can cause more issues.Sionics NP3 BCGNP3 or Nickel PTFE is one option that offers a benefit over standard coatings. NP3 offers improved lubricity, better corrosion resistance, and is easier to clean. Since NP3 is relatively thin, it is not prone to chipping or cracking like some cheaper Nickel Boron options available today. This topic can get exhaustive, so if you want to dive deeper, you can check out the short write-up Sionics has on their website.Now that we're back on track, Sionics' bolt carrier groups have an NP3 coated C158 bolt with a tool steel extractor and ejector. This BCG also uses an enhanced Sprinco extractor spring and Optimized Carrier Key Screws (OCKS) to ensure the gas key doesn't come loose.BRT Chrome BCGHard chrome plating was the original coating used in the late 60s on the XM16 Prototypes; Chrome provides superior corrosion resistance and improved lubricity, much like NP3. Chrome BCGs aren't as common these days as they are expensive to produce, but they are an excellent option